Biopharma Co. Board Sued In Del. For Blocking Director Slate
An investor has sued biopharmaceutical company AIM ImmunoTech Inc. and its three-member board in Delaware Chancery Court, claiming they unfairly prevented him from nominating new blood to join the company's brass....To view the full article, register now.
Already a subscriber? Click here to view full article